Global TB Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global TB Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch. Today, the only effective tuberculosis vaccine in common use is bacilli Calmette-Guérin (BCG), first used in 1921.About three out of every 10,000 people who get the vaccine experience side effects, which are usually minor except in severely immuno-depressed individuals. While BCG immunization provides fairly effective protection for infants and young children, (including defence against TB meningitis and miliary TB), its efficacy in adults is variable, ranging from 0% to 80%.Several variables have been considered as responsible for the varying outcomes. Demand for TB immunotherapy advancement exists because the disease has become increasingly drug-resistant.
TB Vaccines report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global TB Vaccines market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Private Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for TB Vaccines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, TB Vaccines key manufacturers include Merck & Co.,Inc, Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute, India Pvt. Ltd, InterVax Ltd, GreenSignal and Bio Pharma Limited, etc. Merck & Co.,Inc, Sanofi Pasteur, Japan BCG Laboratory are top 3 players and held % sales share in total in 2022.
TB Vaccines can be divided into Immunotherapeutic Vaccines, Booster Vaccines and Others,, etc. Immunotherapeutic Vaccines is the mainstream product in the market, accounting for % sales share globally in 2022.
TB Vaccines is widely used in various fields, such as Hospitals, Private Clinics and Research Institutes,, etc. Hospitals provides greatest supports to the TB Vaccines industry development. In 2022, global % sales of TB Vaccines went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global TB Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Merck & Co.,Inc
Sanofi Pasteur
Japan BCG Laboratory
China National Biotec Group
Serum Institute
India Pvt. Ltd
InterVax Ltd
GreenSignal
Bio Pharma Limited
Statens Serum Institut
Segment by Type
Immunotherapeutic Vaccines
Booster Vaccines
Others
Hospitals
Private Clinics
Research Institutes
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the TB Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of TB Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the TB Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of TB Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, TB Vaccines introduction, etc. TB Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of TB Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
TB Vaccines report published by QYResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global TB Vaccines market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospitals and Private Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for TB Vaccines industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, TB Vaccines key manufacturers include Merck & Co.,Inc, Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute, India Pvt. Ltd, InterVax Ltd, GreenSignal and Bio Pharma Limited, etc. Merck & Co.,Inc, Sanofi Pasteur, Japan BCG Laboratory are top 3 players and held % sales share in total in 2022.
TB Vaccines can be divided into Immunotherapeutic Vaccines, Booster Vaccines and Others,, etc. Immunotherapeutic Vaccines is the mainstream product in the market, accounting for % sales share globally in 2022.
TB Vaccines is widely used in various fields, such as Hospitals, Private Clinics and Research Institutes,, etc. Hospitals provides greatest supports to the TB Vaccines industry development. In 2022, global % sales of TB Vaccines went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global TB Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Merck & Co.,Inc
Sanofi Pasteur
Japan BCG Laboratory
China National Biotec Group
Serum Institute
India Pvt. Ltd
InterVax Ltd
GreenSignal
Bio Pharma Limited
Statens Serum Institut
Segment by Type
Immunotherapeutic Vaccines
Booster Vaccines
Others
Segment by Application
Hospitals
Private Clinics
Research Institutes
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the TB Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of TB Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the TB Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of TB Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, TB Vaccines introduction, etc. TB Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13QYResearch’s Conclusions of TB Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by QYResearch.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices